ikeGPS HY24: revenue down 31.8% and operating cash swings to a NZ$5.2m outflow

What changed

Revenue fell 31.8% to NZ$10.5m from NZ$15.4m, and the result swung from a NZ$1.1m profit before tax to a NZ$6.9m loss. With no tax expense in either period, NPAT equals PBT, so the −718% PBT move is the cleanest read on operating deterioration. Operating cash flow swung from +NZ$0.9m to −NZ$5.2m and pre-lease free cash flow widened to a NZ$6.4m outflow despite capex falling to NZ$1.2m from NZ$2.6m. Cash on hand more than halved to NZ$10.2m from NZ$25.5m, equity fell to NZ$28.0m from NZ$44.0m, and total liabilities rose 21.4% even as total assets contracted 26.5%. Within the mix, Platform Transactions revenue fell to NZ$3.7m from NZ$9.5m (61.3% → 35.6% of disclosed segment revenue), while Platform Subscriptions revenue at NZ$2.4m carries the highest inferred contribution margin of the disclosed segments.

What matters

• Transaction revenue is the swing factor. The release attributes the shortfall to delays in engineering projects with long-term customers, with multi-year volumes "expected to resume". That framing is qualitative; there is no quantified pipeline or forward-work disclosure to verify the timing claim.
• Cash runway is now the constraint, not a comfort. At NZ$10.2m cash and a NZ$5.2m half-year operating outflow plus NZ$1.2m capex, the trajectory is roughly one year of self-funded runway absent a recovery. Management has flagged Q3 cost reductions to "accelerate time to EBITDA breakeven", but no breakeven date or quantified cost-out figure is given.
• Working capital absorbed cash on top of the P&L loss. Receivable days deteriorated to about 105 from 46, lifting trade debtors to NZ$6.1m from NZ$3.9m on lower revenue — a meaningful piece of the cash swing that is independent of the trading shortfall itself.

Expectations

No FY24 guidance, forward-work disclosure, or quantified target was provided in this release, so the result cannot be benchmarked against an explicit anchor. Annualising HY24 revenue gives roughly NZ$21.0m, around 31.7% below FY23's NZ$30.8m base. The FY23 shape is not a clean precedent: HY23 was 50.1% of FY23 revenue, but FY23 NPAT was negative and second-half-loaded. The release does not commit to a second-half recovery in transaction volumes within FY24, only that multi-year volumes are "expected to resume", so the current run-rate is what the filing supports rather than the FY23 base.

Quality of result

The result is low-quality on multiple axes. The earnings swing is operating, not tax- or one-off-driven (no non-recurring items disclosed, no non-GAAP reconciliation, no tax distortion). Subscriptions growth of 24% is the bright spot and should be more durable, but it is too small at NZ$2.4m to offset the transaction shortfall. Cash conversion deteriorated materially: the OCF outflow exceeds the NPAT loss, and receivables built up against a falling revenue line, so the cash result is worse than the P&L suggests rather than balance-sheet-assisted. Capex was halved, which flatters the FCF line versus what a steady-state investment level might look like. FX added NZ$0.3m to cash and is flagged as material in the calculation pass without a hedging disclosure.

Unresolved

• What is the named customer or project delay, the expected timing of resumption, and the dollar value of contracted volume now expected to slip into FY25?
• What is the quantum and run-rate impact of the Q3 cost reductions, and on what revenue assumption does management's "EBITDA breakeven" path rely?
• Why did receivables rise 56.3% on a 31.8% revenue decline, and is any of the NZ$6.1m balance at risk?
• Is any of the NZ$10.2m cash restricted, and what is the board's stance on raising capital if the transaction recovery is delayed beyond FY24?

This briefing cannot assess the credibility of the "multi-year volumes expected to resume" claim, because no forward-work, contract-coverage, or pipeline figure was disclosed in the extracted release.

Key metrics

Segment breakdown

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.